XT
ELDN icon

XTX Topco’s Eledon Pharmaceuticals ELDN Stock Holding History

XTX Topco’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Sell
38,307
-27,928
-42% -$102K ﹤0.01% 3378
2026
Q1 		$204K Sell
66,235
-58,012
-47% -$137K ﹤0.01% 2833
2025
Q4 		$188K Buy
124,247
+111,399
+867% +$265K ﹤0.01% 2429
2025
Q3 		$33.3K Buy
+12,848
New +$37.6K ﹤0.01% 2247

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

XTX Topco's ELDN Position: Q2 2026 in Review

XTX Topco reduced its Eledon Pharmaceuticals (ELDN) stake by 42% in Q2 2026, selling an estimated $102K and leaving 38,307 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #3378.

XTX Topco first reported a position in ELDN in Q3 2025 and has held it in 4 quarters since. The position peaked at $204K in Q1 2026. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • XTX Topco held 38,307 shares of Eledon Pharmaceuticals worth $151K as of Q2 2026.
  • XTX Topco sold 27,928 Eledon Pharmaceuticals shares in Q2 2026, an estimated $102K.
  • Eledon Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3378 holding.
  • XTX Topco first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • XTX Topco's Eledon Pharmaceuticals position peaked at $204K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.